Interestingly, a significant difference was obtained in the expression of G0S2, DYSF, MMP9, SLC22A4, SELP, and KCNJ15 between ccRCC patients with high-grade and low-grade tumors (Figure 9D, all p < 0.05). This evidence concerns the gene MMP9 and nonpapillary renal cell carcinoma.